Bomac has a substantial commitment to R&D to ensure a constant stream of innovative products are developed, registered and launched in various countries. A strong in-house team of formulators and analytical experts are supported with fully equipped laboratory. The projects are market and science driven and many new products, innovative or enhanced performance are launched each year.
Full dossiers are developed to international standards generally including Development Pharmaceutics, Material Specifications, Analytical method and Validation, Stability Data to VICH Standards and Efficacy, Safety, Residue and Toxicity data, dependent on species and product type. These files will generally satisfy almost any International Regulator around the world.
So Bomac offers exciting innovative products and packaging technology with full support packages to allow local registrations. The Company has a wide range of products and continues to develop product for most species and using various modes of administration. From Injectable to Oral, topical to transdermal, feed additives to Water Soluble Solutions and across all species.
There are a wide range of products developed but a few particular Research Themes are discussed here
Anthelmintics
Bomac has developed an extensive range of Anthelmintics for Cattle, Sheep, Pigs, Dogs, Cats and Horses. The newest compounds are used such as Eprinomectin, Doramectin and Moxidectin in various dosage forms, but most importantly in combinations as well to ensure the control of resistant parasites. in various species. THE product list some of the latest but several more products are nearing Approval in New Zealand, ask for a full list of what is coming.
Reproduction
The treatment of anoestrus and the provisions of synchrony have become major issues for dairy, beef and some sheep production. in many countries. Bomac has committed resources to develop products and programs which are customised to various markets with substantial reproductive improvements, proven by extensive trial work.
Mastitis
Bomac has a special Company, Mastitis Research Centre Ltd with the commitment to leading the World in Mastitis Research. This program has run for several years in order to understand the disease, causative organisms, morphological and physiological factors that impact the Disease and identifying for the formulation team, key factors effecting Distribution, Absorption and Elimination of Drugs in the udder. This work is now showing considerable output and several innovative products and programs are rolling out. If you have a market for Dairy cows, you need to be talking to Bomac.
|
